WithdrawnNot Applicable

Regional Anesthesia for Breast Surgery

Stopped: study never started

Italy0Started 2019-05-29

Plain-language summary

Patients scheduled for mastecotmy will be randomized to receive either an ultrasound-guided double space paravertebral block or a PECSII + parasternal block. In both groups, blocks will be performed with 20 ml of ropivacaine 0.75%, plus ropivacaine 0.375% 10 ml for parasternal block only. Postoperative, all patients will receive a morphine PCA. They will follow at 6, 12, 24 months for persistent postoperative surgical pain (PPSP) and cancer recurrence.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients scheduled for radical mastectomy for cancer. * age \> 18 y-o * Written informed consent Exclusion Criteria: * Bilateral surgery * Opioids user * BMI \> 35 * Postoperative Intensive care

What they're measuring

Morphine requirement

Timeframe: 1 day

Trial details

NCT IDNCT03941223

SponsorAzienda USL Reggio Emilia - IRCCS

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2023-12-31

View on ClinicalTrials.gov More Breast Cancer trials